Biotechnology Stocks I Performance Guide: Rhythm Pharmaceuticals, Inc. (RYTM)
RYTM has no dividends.
Table and Chart of RYTM Performance
See what a $1,000 investment in RYTM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RYTM Returns | |
|---|---|
| Start Date | Nov-30-2017 |
| Start Price | $28.58 |
| End Date | Oct-11-2024 |
| End Price | $49.82 |
| # Prices | 84 |
| Min Date | May-31-2022 |
| Min Price | $3.44 |
| Max Date | Sep-30-2024 |
| Max Price | $52.39 |
| Total Return | 74.32% |
| Annualized Return | 8.26% |
| Current Value of $1,000 Purchase | $1,743 |
| Number Returns | 3,486 |
| Average Return | 35.46% |
| Number Profitable Returns | 1,718 |
| Percent Profitable Returns | 49.28% |
| Number Unprofitable Returns | 1,768 |
| Percent Unprofitable Returns | 50.72% |
| Profitable to Unprofitable Returns Ratio | 0.97 |
| RYTM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -12.650 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -263939008 |
| PE to Growth Ratio | None |
| Price to Book | 29.92 |
| PRICE DATA | |
| 52 Week High | $2.075 |
| 52 Week Low | $55.64 |
| Analyst Target Price | $0.513 |
| 50-Day Moving Average | $21.34 |
| 200-Day Moving Average | $48.3 |
| FINANCIAL DATA | |
| Revenue per Share | $-4.35 |
| Revenue | $-1 |
| Profit Margin | 170.9% |
| Return on Equity | -48% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RYTM Compare Returns with S&P 500
RYTM Trendline Chart
RYTM Moving Average Chart
RYTM Stock Return Map - See Patterns of Gains and Losses
RYTM Stock Returns/Purchase Dates